Dr Reddys Laboratories Ltd Share Price Today - Live Blog for May 15, 2026

After a notable 2.55% increase, Dr Reddys Laboratories Ltd's shares are now trading at 1336.90. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.2041 and an ROE of 11.0737.

Dr Reddys Laboratories Ltd's shares saw an increase of 1.69%, reaching the current market price of 1325.60. This development underscores the stock's growing popularity.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 1.69% increase and currently trading at 1325.60 per share. This upward trajectory is turning heads in the market.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 1.39% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1321.70 per share. The stock has an ROE of 11.0737 and debt to equity ratio of 0.2041.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 1.39%, and as of now, it's trading at 1321.70 per share. This upward trajectory is attracting keen interest from investors.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 1.24% boost, with the current market value at 1319.80 per share. This surge has not gone unnoticed by investors.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 1.24% gain, with the share price now at 1319.80. Notably, the stock's PE ratio stands at 26.1600, and its Return on Equity (ROE) is 11.0737.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 1.55% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1323.80 per share. The stock has an ROE of 11.0737 and debt to equity ratio of 0.2041.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 1.55% increase and currently trading at 1323.80 per share. Investors are taking notice of this upward momentum.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 1.79% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1326.90 per share. The stock has an ROE of 11.0737 and debt to equity ratio of 0.2041.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 1.79%, with its current market value per share resting at 1326.90. This development highlights the stock's appeal to investors.